Literature DB >> 35236717

Could Phosphate Provide a Second Chance for Statin Therapy in Kidney Failure?

Orlando M Gutiérrez1.   

Abstract

Entities:  

Keywords:  phosphorus; statin therapy

Mesh：

Substances：

Year:  2022        PMID： 35236717      PMCID： PMC8993483          DOI： 10.2215/CJN.02210222

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

Review 2.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

3.  Clinical outcomes in statin treatment trials: a meta-analysis.

Authors:  S D Ross; I E Allen; J E Connelly; B M Korenblat; M E Smith; D Bishop; D Luo
Journal:  Arch Intern Med       Date:  1999 Aug 9-23

4.  Cause of Death in Patients with Reduced Kidney Function.

Authors:  Stephanie Thompson; Matthew James; Natasha Wiebe; Brenda Hemmelgarn; Braden Manns; Scott Klarenbach; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2015-03-02       Impact factor: 10.121

5.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

6.  Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients.

Authors:  Ziad A Massy; Thomas Merkling; Sandra Wagner; Nicolas Girerd; Marie Essig; Christoph Wanner; Bengt C Fellstrom; Patrick Rossignol; Faiez Zannad
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 8.237

Review 7.  End-stage renal disease in the United States: an update from the United States Renal Data System.

Authors:  Robert N Foley; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2007-07-26       Impact factor: 10.121

8.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245

9.  Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans.

Authors:  Chao Zhou; Quan He; Hua Gan; Tingting Zeng; Qiao Liu; John F Moorhead; Zac Varghese; Nan Ouyang; Xiong Z Ruan
Journal:  Kidney Int       Date:  2021-02-23       Impact factor: 10.612

10.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Authors:  Colin Baigent; Martin J Landray; Christina Reith; Jonathan Emberson; David C Wheeler; Charles Tomson; Christoph Wanner; Vera Krane; Alan Cass; Jonathan Craig; Bruce Neal; Lixin Jiang; Lai Seong Hooi; Adeera Levin; Lawrence Agodoa; Mike Gaziano; Bertram Kasiske; Robert Walker; Ziad A Massy; Bo Feldt-Rasmussen; Udom Krairittichai; Vuddidhej Ophascharoensuk; Bengt Fellström; Hallvard Holdaas; Vladimir Tesar; Andrzej Wiecek; Diederick Grobbee; Dick de Zeeuw; Carola Grönhagen-Riska; Tanaji Dasgupta; David Lewis; William Herrington; Marion Mafham; William Majoni; Karl Wallendszus; Richard Grimm; Terje Pedersen; Jonathan Tobert; Jane Armitage; Alex Baxter; Christopher Bray; Yiping Chen; Zhengming Chen; Michael Hill; Carol Knott; Sarah Parish; David Simpson; Peter Sleight; Alan Young; Rory Collins
Journal:  Lancet       Date:  2011-06-12       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.